AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.
Over the last 12 months, insiders at AVITA Medical, Inc. have bought $42,789 and sold $0 worth of AVITA Medical, Inc. stock.
On average, over the past 5 years, insiders at AVITA Medical, Inc. have bought $83,489 and sold $720,423 worth of stock each year.
Highest buying activity among insiders over the last 12 months: O'Toole David D (CFO) — $171,157.
The last purchase of 975 shares for transaction amount of $12,152 was made by O'Toole David D (CFO) on 2024‑12‑05.
2024-12-05 | CFO | 975 0.0037% | $12.46 | $12,152 | +2.89% | |||
2024-05-30 | CFO | 1,000 0.0037% | $8.90 | $8,900 | +10.56% | |||
2024-02-28 | CFO | 1,250 0.005% | $17.39 | $21,738 | -39.30% | |||
2023-12-26 | Sale | CEO | 1,445 0.0057% | $13.29 | $19,204 | -22.30% | ||
2023-12-21 | Sale | director | 2,500 0.01% | $12.49 | $31,225 | -14.06% | ||
2023-12-13 | Sale | director | 2,518 0.0095% | $12.27 | $30,896 | -17.57% | ||
2023-12-12 | CFO | 950 0.0039% | $12.45 | $11,828 | -11.27% | |||
2023-12-01 | CFO | 500 0.0019% | $10.68 | $5,340 | -4.36% | |||
2023-11-21 | CFO | 2,000 0.008% | $10.28 | $20,560 | +5.53% | |||
2023-11-16 | CFO | 1,000 0.0038% | $12.15 | $12,150 | -15.28% | |||
2023-11-15 | CFO | 2,000 0.0078% | $12.85 | $25,700 | -17.64% | |||
2023-11-15 | CFO | 1,000 0.0038% | $12.45 | $12,450 | -17.64% | |||
2023-11-14 | CFO | 1,000 0.0037% | $12.88 | $12,880 | -20.43% | |||
2023-08-21 | Sale | General Counsel | 4,193 0.0162% | $15.84 | $66,417 | -22.96% | ||
2023-08-16 | CFO | 2,000 0.0081% | $17.05 | $34,110 | -24.73% | |||
2023-08-15 | CFO | 5,000 0.0201% | $17.93 | $89,640 | -28.72% | |||
2023-06-20 | CFO | 1,000 0.004% | $16.15 | $16,150 | -11.58% | |||
2022-02-24 | Sale | Chief Executive Officer | 10,812 0.0423% | $8.74 | $94,497 | -27.15% | ||
2021-09-20 | director | 1,066 0.0043% | $17.08 | $18,207 | -50.62% | |||
2021-09-01 | Sale | Chief Executive Officer | 11,220 0.0447% | $20.68 | $232,030 | -57.95% |
O'Toole David D | CFO | 23734 0.0905% | $8.65 | 13 | 0 | <0.0001% |
PERRY MICHAEL S | Chief Executive Officer | 321712 1.2271% | $8.65 | 0 | 8 | |
Shiroma Donna | General Counsel | 42257 0.1612% | $8.65 | 0 | 1 | |
COOK JEREMY CURNOCK | director | 20614 0.0786% | $8.65 | 0 | 2 | |
CORBETT JAMES | CEO | 11580 0.0442% | $8.65 | 0 | 1 | |
Crowe Suzanne | director | 4112 0.0157% | $8.65 | 1 | 0 | <0.0001% |
McIntyre David | Chief Financial Officer | 893 0.0034% | $8.65 | 2 | 0 | <0.0001% |
BlackRock | $28.05M | 6.78 | 1.75M | -3.13% | -$906,801.06 | <0.01 | |
The Vanguard Group | $22.57M | 5.46 | 1.41M | +1.1% | +$246,156.68 | <0.0001 | |
State Street | $15.08M | 3.65 | 941,041 | +88.09% | +$7.06M | <0.01 | |
Geode Capital Management | $8.71M | 2.11 | 543,016 | +2.72% | +$230,207.68 | <0.01 | |
Awm Investment Company Inc | $7.97M | 1.93 | 496,952 | 0% | +$0 | 1.21 | |
Silvercrest Asset Management Group Inc | $3.87M | 0.94 | 241,665 | New | +$3.87M | 0.03 | |
Northern Trust | $3.5M | 0.85 | 218,134 | -3.13% | -$112,947.38 | <0.01 | |
Centerbook Partners Lp | $2.33M | 0.56 | 145,347 | +751.08% | +$2.06M | 0.16 | |
BNY Mellon | $1.72M | 0.42 | 107,608 | -7.77% | -$145,392.16 | <0.0001 | |
AQR Capital | $1.45M | 0.35 | 90,600 | +45.64% | +$455,107.73 | <0.01 | |
Goldman Sachs | $1.3M | 0.31 | 80,905 | +191.36% | +$851,786.01 | <0.0001 | |
GlobeFlex Capital | $1.23M | 0.3 | 76,856 | 0% | +$0 | 0.12 | |
Soleus Capital Management, L.P. | $1.2M | 0.29 | 75,000 | 0% | +$0 | 0.01 | |
1492 Capital Management, LLC | $1.15M | 0.28 | 71,929 | 0% | +$0 | 0.64 | |
Nuveen | $1.15M | 0.28 | 71,738 | 0% | +$0 | <0.0001 | |
Charles Schwab | $1.08M | 0.26 | 67,300 | -2.51% | -$27,763.96 | <0.0001 | |
Wellington Management Company | $1.05M | 0.25 | 65,413 | +134.62% | +$601,637.74 | <0.0001 | |
Ameriprise Financial | $830,626.00 | 0.2 | 51,817 | -47.49% | -$751,245.49 | <0.0001 | |
UBS | $825,802.00 | 0.2 | 51,516 | +157.49% | +$505,089.59 | <0.0001 | |
Rafferty Asset Management Llc | $827,148.00 | 0.2 | 51,600 | New | +$827,148.00 | <0.01 | |
D. E. Shaw & Co. | $771,508.00 | 0.19 | 48,129 | -4.8% | -$38,904.82 | <0.01 | |
Citigroup | $753,185.00 | 0.18 | 46,986 | +1,220.57% | +$696,150.30 | <0.01 | |
Dimensional Fund Advisors | $729,910.00 | 0.18 | 45,534 | -52.46% | -$805,395.27 | <0.0001 | |
GOLDEN CAPITAL MANAGEMENT LLC | $689,691.00 | 0.17 | 43,025 | +230.96% | +$481,300.92 | 0.02 | |
Hussman Strategic Advisors Inc | $673,260.00 | 0.16 | 42,000 | New | +$673,260.00 | 0.16 | |
Morgan Stanley | $638,250.00 | 0.15 | 39,816 | -36.09% | -$360,386.19 | <0.0001 | |
Pura Vida Investments LLC | $561,050.00 | 0.14 | 35,000 | -90.31% | -$5.23M | 0.4 | |
RhumbLine Advisers | $514,026.00 | 0.12 | 32,067 | +3.36% | +$16,719.03 | <0.0001 | |
Ohio Strs | $506,000.00 | 0.12 | 31,600 | -23.11% | -$152,120.25 | <0.01 | |
Bank of America | $486,046.00 | 0.12 | 30,321 | -20.77% | -$127,438.60 | <0.0001 | |
Renaissance Technologies | $378,000.00 | 0.09 | 23,600 | -35.87% | -$211,423.73 | <0.01 | |
Susquehanna International Group | $331,324.00 | 0.08 | 20,669 | -53.12% | -$375,358.40 | <0.0001 | |
Clearline Capital LP | $331,212.00 | 0.08 | 20,662 | 0% | +$0 | 0.03 | |
Barclays | $325,000.00 | 0.08 | 20,336 | -41.02% | -$226,042.49 | <0.0001 | |
Citadel Advisors LLC | $284,212.00 | 0.07 | 17,730 | +427.21% | +$230,303.09 | <0.0001 | |
Financial Advisory Group | $248,802.00 | 0.06 | 15,521 | +19.2% | +$40,075.06 | 0.05 | |
Deutsche Bank | $244,538.00 | 0.06 | 15,255 | -5.11% | -$13,176.68 | <0.0001 | |
T. Rowe Price | $232,000.00 | 0.06 | 14,459 | +8.37% | +$17,922.68 | <0.0001 | |
MetLife Investment Management | $218,729.00 | 0.05 | 13,645 | 0% | +$0 | <0.01 | |
Jane Street Capital | $208,149.00 | 0.05 | 12,985 | -47.09% | -$185,242.19 | <0.0001 | |
American International Group | $198,596.00 | 0.05 | 12,389 | -0.85% | -$1,699.18 | <0.01 | |
Two Sigma Advisers LP | $192,360.00 | 0.05 | 12,000 | -68.99% | -$428,001.00 | <0.0001 | |
Franklin Templeton Investments | $188,673.00 | 0.05 | 11,770 | New | +$188,673.00 | <0.0001 | |
Invesco | $175,913.00 | 0.04 | 10,974 | -61.36% | -$279,354.46 | <0.0001 | |
JPMorgan Chase | $164,853.00 | 0.04 | 10,284 | -38.15% | -$101,694.62 | <0.0001 | |
Wells Fargo | $152,638.00 | 0.04 | 9,522 | +11.8% | +$16,110.19 | <0.0001 | |
New York State Common Retirement Fund | $151,000.00 | 0.04 | 9,421 | +17.44% | +$22,423.20 | <0.0001 | |
LAZARD ASSET MANAGEMENT LLC | $87,000.00 | 0.02 | 5,428 | -6.67% | -$6,218.86 | <0.0001 | |
Advisor Group Holdings Inc | $54,388.00 | 0.01 | 3,393 | +4.34% | +$2,260.16 | <0.0001 | |
Legal & General | $43,585.00 | 0.01 | 2,719 | -3.07% | -$1,378.56 | <0.0001 |